ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 5,500 shares of the company's stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $19.57, for a total value of $107,635.00. Following the sale, the chief executive officer owned 147,000 shares of the company's stock, valued at approximately $2,876,790. The trade was a 3.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
ReposiTrak Price Performance
Shares of ReposiTrak stock traded down $0.21 during trading on Thursday, reaching $19.50. 34,568 shares of the company's stock were exchanged, compared to its average volume of 50,342. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.03 and a current ratio of 6.03. ReposiTrak Inc. has a 1-year low of $15.72 and a 1-year high of $25.01. The stock has a market capitalization of $356.46 million, a P/E ratio of 57.35 and a beta of 0.51.
ReposiTrak Cuts Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Stockholders of record on Monday, June 30th will be issued a dividend of $0.0182 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.37%. ReposiTrak's dividend payout ratio (DPR) is currently 20.59%.
Hedge Funds Weigh In On ReposiTrak
An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC boosted its position in ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,289 shares of the company's stock after purchasing an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 at the end of the most recent quarter. 27.35% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Wall Street Zen raised ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.
Check Out Our Latest Stock Report on TRAK
ReposiTrak Company Profile
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
See Also
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
